Roselabs Finance Q1FY26 Results: Net Loss Widens to ₹4.68 Lakh; Stocks Fall by 5%
By Shishta Dutta | Updated at: Jan 9, 2026 01:52 PM IST
Mumbai, July 18, 2025 – Roselabs Finance Limited (BSE: 531324) reported a net loss of ₹4.68 lakh for the quarter ended June 30, 2025 (Q1FY26), marginally wider than the ₹4.40 lakh loss in Q1FY25, as the company remained devoid of operating revenue and incurred routine administrative expenses.
Roselabs Finance Stock Movement
The share of the company declined by 5% today (closed at ₹28.50), which was also the lowest point for the day. The stock had originally opened in green and reached a high point of ₹31.50. With a 5% intraday decline, the stock has approached its 52-week low of ₹25.45. The traded volume also remained low, around 1000 shares.
Financial Highlights: Q1FY26 vs Q1FY25
| Particulars | Q1FY26 (₹ lakh) | Q4FY25 (₹ lakh) | Q1FY25 (₹ lakh) | FY25 (₹ lakh) |
|---|---|---|---|---|
| Revenue from operations | 0.00 | 70.91 | 0.00 | 70.91 |
| Other income | 0.00 | 0.00 | 0.00 | 1.68 |
| Total income | 0.00 | 70.91 | 0.00 | 72.59 |
| Cost of projects | 0.00 | 70.20 | 0.00 | 70.20 |
| Employee benefits expense | 2.34 | 1.42 | 1.24 | 5.95 |
| Other expenses | 2.34 | 3.83 | 3.16 | 25.61 |
| Total expenses | 4.68 | 75.45 | 4.40 | 101.74 |
| Profit / (Loss) before tax | (4.68) | (4.54) | (4.40) | (29.17) |
| EPS – Basic & Diluted (₹) | (0.05) | (0.05) | (0.04) | (0.29) |
The company did not report any revenue in the June quarter, similar to the corresponding quarter last year. Total expenses stood at ₹4.68 lakh in Q1 FY26, up from ₹4.40 lakh in Q1 FY25, primarily due to increased employee-related and administrative costs.
Auditor’s Opinion
The unaudited financial results were reviewed by MSKA & Associates, who issued an unmodified review report. According to their assessment, no material misstatements were identified, and the report complies with the SEBI Listing Regulations and the requirements of Ind AS 34.
Corporate Updates
The Board of Directors has scheduled the 31st Annual General Meeting for September 26, 2025.
Additionally, Roselabs reaffirmed its strategic alignment with its parent company. As per board approval dated July 30, 2024, a Scheme of Merger by absorption with Lodha Developers Limited (formerly Macrotech Developers) is underway, subject to regulatory clearances under Sections 230-232 of the Companies Act, 2013.
Segment Information
As clarified in the notes, the company operates solely in the real estate development segment, rendering segmental reporting under Ind AS 108 inapplicable.
Company Overview
Roselabs Finance Limited is listed on the BSE and is engaged in real estate development. It is part of the Lodha Group ecosystem, with ongoing strategic efforts to consolidate operations with Lodha Developers Limited. The company’s equity share capital stands at ₹1,000 lakh with no revenue-generating activities during the reporting quarter.
REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/44588876-08a0-46f0-985f-7575c81f16cf.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
